Immunis Inc.
Author: Michael
BioAge, a Richmond, California–based biotechnol
Aspen Neuroscience has completed dose escalation
Haya Therapeutics, a biotech firm pioneering prec
Revalia Bio lands funding to scale up drug testi
Investment from Allen Law’s Seveno Capital ref
With a platform designed to preserve mitochondri
Renue By Science has introduced Renue Blue Face C
Winona has introduced a comprehensive 2025 telehe
Biomarkers of Aging Conference 2025 convenes lea